Oncopeptides Year-End Cash SEK 360 Million After Cutting Costs

(PLX AI) – Oncopeptides cash position at year-end 2021 was approximately SEK 360 million.Cash burn reduced to SEK 12-15 million monthly for 2022 from SEK 130 million monthly in March-October 2021Says cash flow in 2022 will, in addition to the …